Cost-Effectiveness of Symptom Monitoring with Patient-Reported Outcomes During Routine Cancer Treatment

Conclusions The results of this analysis show that for a cost increase of $3,360 CAD, the use of a PRO tool for symptom monitoring yields an additional 0.25 QALYs. At a cost per QALY of ∼$13,450, this would be considered good value for money at the typically accepted Canadian standard of $50,000 per QALY.
Source: Journal of Cancer Policy - Category: Cancer & Oncology Source Type: research